BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3560974)

  • 21. Comparative effects of calcium channel blocking agents and varying extracellular calcium concentration on hypoxia/reoxygenation and ischemia/reperfusion-induced cardiac injury.
    Fitzpatrick DB; Karmazyn M
    J Pharmacol Exp Ther; 1984 Mar; 228(3):761-8. PubMed ID: 6707924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Negative chronotropic and positive inotropic actions of phencyclidine on isolated atrial muscle in guinea pigs and rats.
    Temma K; Akera T; Brody TM; Rech RH
    J Pharmacol Exp Ther; 1983 Sep; 226(3):885-92. PubMed ID: 6887016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cardiotropic agents on the myocardial dysfunction of hyperdynamic sepsis.
    McDonough KH; Lang CH; Spitzer JJ
    Circ Shock; 1985; 17(1):1-19. PubMed ID: 4053297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do calcium antagonists act directly on calcium channels to alter baroreceptor function?
    Kunze DL; Andresen MC; Torres LA
    J Pharmacol Exp Ther; 1986 Nov; 239(2):303-10. PubMed ID: 2430091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure.
    Dong H; Earle ML; Jiang Y; Loutzenhiser KA; Triggle CR
    Br J Pharmacol; 1997 Dec; 122(7):1271-8. PubMed ID: 9421272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal differences in actions of calcium channel blockers on K+ accumulation, cardiac function, and high-energy phosphate levels in ischemic guinea pig hearts.
    Sato R; Yamazaki J; Nagao T
    J Pharmacol Exp Ther; 1999 May; 289(2):831-9. PubMed ID: 10215660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcium antagonistic effect of Xanthotoxol on isolated guinea pig atria].
    Liu J; Lian Q; Zhou L; Zhou Q; He W; Zhu Z; Lai F
    Zhong Yao Cai; 2005 Apr; 28(4):319-21. PubMed ID: 16104510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
    Mirkhani H; Dirin M; Youssef-Zayeh I
    Vascul Pharmacol; 2004 Aug; 42(1):23-9. PubMed ID: 15664884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of chronic calcium channel blocker treatment on the inotropic response of diabetic rat myocardium to acute ethanol exposure.
    Brown RA; Sundareson AM; Lee MM; Savage AO
    Life Sci; 1996; 59(10):835-47. PubMed ID: 8761317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive inotropic effects of calcium channel antagonists are not necessarily caused by partial calcium channel agonism.
    Punt NC; van Amsterdam FT; Goddijn MM; Haas M; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):211-4. PubMed ID: 3185748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium ions and the influence of chagasic sera on the effects of ouabain on isolated rat atria.
    Sterin-Borda L; Canga L; Cossio PM; Diez C; Arana RM; Gimeno AL
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):93-108. PubMed ID: 6268007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PY 108-068, a dihydropyridine derivative, and verapamil interact differently with the ouabain effects on the heart and the peripheral circulation.
    Hof RP; Hof A
    Basic Res Cardiol; 1985; 80(1):66-75. PubMed ID: 3985926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular calcium concentration and calcium blocking agents on the action of ouabain on isolated rat atrium.
    Canga L; Sterin-Broda L; Gimeno AL
    Pharmacol Res Commun; 1982 Jan; 14(1):15-30. PubMed ID: 7071098
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antagonism of verapamil on the injurious action of endothelin of isolated rat heart].
    Tang CS; Li ZP; Tang J; Su JY
    Sheng Li Xue Bao; 1990 Aug; 42(4):374-8. PubMed ID: 2175946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differing potencies and dose-response characteristics in the ability of slow-calcium-channel blockers to reduce enzyme leakage in the calcium paradox.
    Baker JE; Hearse DJ
    Adv Myocardiol; 1985; 6():637-46. PubMed ID: 2581302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
    Hallaq H; Hasin Y; Fixler R; Eilam Y
    J Pharmacol Exp Ther; 1989 Feb; 248(2):716-21. PubMed ID: 2918476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a new calcium antagonist, Rec 15/2375, on cardiac contractility of conscious rabbits.
    Bianchi G; Passoni A; Griffini PL
    Pharmacol Res; 1989; 21(2):193-200. PubMed ID: 2748506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.